Cargando…

A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma

BACKGROUND: Cuproptosis, a recently discovered form of cell death, is caused by copper levels exceeding homeostasis thresholds. Although Cu has a potential role in colon adenocarcinoma (COAD), its role in the development of COAD remains unclear. METHODS: In this study, 426 patients with COAD were ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Like, Zhu, Junfeng, Shu, Qi, Xu, Gaoqi, He, Chaoneng, Fang, Luo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957631/
https://www.ncbi.nlm.nih.gov/pubmed/36844874
http://dx.doi.org/10.1155/2023/5925935
_version_ 1784894869256273920
author Zhong, Like
Zhu, Junfeng
Shu, Qi
Xu, Gaoqi
He, Chaoneng
Fang, Luo
author_facet Zhong, Like
Zhu, Junfeng
Shu, Qi
Xu, Gaoqi
He, Chaoneng
Fang, Luo
author_sort Zhong, Like
collection PubMed
description BACKGROUND: Cuproptosis, a recently discovered form of cell death, is caused by copper levels exceeding homeostasis thresholds. Although Cu has a potential role in colon adenocarcinoma (COAD), its role in the development of COAD remains unclear. METHODS: In this study, 426 patients with COAD were extracted from the Cancer Genome Atlas (TCGA) database. The Pearson correlation algorithm was used to identify cuproptosis-related lncRNAs. Using the univariate Cox regression analysis, the least absolute shrinkage and selection operator (LASSO) was used to select cuproptosis-related lncRNAs associated with COAD overall survival (OS). A risk model was established based on the multivariate Cox regression analysis. A nomogram model was used to evaluate the prognostic signature based on the risk model. Finally, mutational burden and sensitivity analyses of chemotherapy drugs were performed for COAD patients in the low- and high-risk groups. RESULT: Ten cuproptosis-related lncRNAs were identified and a novel risk model was constructed. A signature based on ten cuproptosis-related lncRNAs was an independent prognostic predictor for COAD. Mutational burden analysis suggested that patients with high-risk scores had higher mutation frequency and shorter survival. CONCLUSION: Constructing a risk model based on the ten cuproptosis-related lncRNAs could accurately predict the prognosis of COAD patients, providing a fresh perspective for future research on COAD.
format Online
Article
Text
id pubmed-9957631
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-99576312023-02-25 A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma Zhong, Like Zhu, Junfeng Shu, Qi Xu, Gaoqi He, Chaoneng Fang, Luo J Oncol Research Article BACKGROUND: Cuproptosis, a recently discovered form of cell death, is caused by copper levels exceeding homeostasis thresholds. Although Cu has a potential role in colon adenocarcinoma (COAD), its role in the development of COAD remains unclear. METHODS: In this study, 426 patients with COAD were extracted from the Cancer Genome Atlas (TCGA) database. The Pearson correlation algorithm was used to identify cuproptosis-related lncRNAs. Using the univariate Cox regression analysis, the least absolute shrinkage and selection operator (LASSO) was used to select cuproptosis-related lncRNAs associated with COAD overall survival (OS). A risk model was established based on the multivariate Cox regression analysis. A nomogram model was used to evaluate the prognostic signature based on the risk model. Finally, mutational burden and sensitivity analyses of chemotherapy drugs were performed for COAD patients in the low- and high-risk groups. RESULT: Ten cuproptosis-related lncRNAs were identified and a novel risk model was constructed. A signature based on ten cuproptosis-related lncRNAs was an independent prognostic predictor for COAD. Mutational burden analysis suggested that patients with high-risk scores had higher mutation frequency and shorter survival. CONCLUSION: Constructing a risk model based on the ten cuproptosis-related lncRNAs could accurately predict the prognosis of COAD patients, providing a fresh perspective for future research on COAD. Hindawi 2023-02-17 /pmc/articles/PMC9957631/ /pubmed/36844874 http://dx.doi.org/10.1155/2023/5925935 Text en Copyright © 2023 Like Zhong et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Zhong, Like
Zhu, Junfeng
Shu, Qi
Xu, Gaoqi
He, Chaoneng
Fang, Luo
A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma
title A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma
title_full A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma
title_fullStr A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma
title_full_unstemmed A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma
title_short A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma
title_sort prognostic cuproptosis-related lncrna signature for colon adenocarcinoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957631/
https://www.ncbi.nlm.nih.gov/pubmed/36844874
http://dx.doi.org/10.1155/2023/5925935
work_keys_str_mv AT zhonglike aprognosticcuproptosisrelatedlncrnasignatureforcolonadenocarcinoma
AT zhujunfeng aprognosticcuproptosisrelatedlncrnasignatureforcolonadenocarcinoma
AT shuqi aprognosticcuproptosisrelatedlncrnasignatureforcolonadenocarcinoma
AT xugaoqi aprognosticcuproptosisrelatedlncrnasignatureforcolonadenocarcinoma
AT hechaoneng aprognosticcuproptosisrelatedlncrnasignatureforcolonadenocarcinoma
AT fangluo aprognosticcuproptosisrelatedlncrnasignatureforcolonadenocarcinoma
AT zhonglike prognosticcuproptosisrelatedlncrnasignatureforcolonadenocarcinoma
AT zhujunfeng prognosticcuproptosisrelatedlncrnasignatureforcolonadenocarcinoma
AT shuqi prognosticcuproptosisrelatedlncrnasignatureforcolonadenocarcinoma
AT xugaoqi prognosticcuproptosisrelatedlncrnasignatureforcolonadenocarcinoma
AT hechaoneng prognosticcuproptosisrelatedlncrnasignatureforcolonadenocarcinoma
AT fangluo prognosticcuproptosisrelatedlncrnasignatureforcolonadenocarcinoma